David Doyle

7.3k total citations
94 papers, 5.6k citations indexed

About

David Doyle is a scholar working on Rheumatology, Surgery and Orthopedics and Sports Medicine. According to data from OpenAlex, David Doyle has authored 94 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Rheumatology, 18 papers in Surgery and 18 papers in Orthopedics and Sports Medicine. Recurrent topics in David Doyle's work include Osteoarthritis Treatment and Mechanisms (23 papers), Rheumatoid Arthritis Research and Therapies (17 papers) and Bone health and osteoporosis research (15 papers). David Doyle is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (23 papers), Rheumatoid Arthritis Research and Therapies (17 papers) and Bone health and osteoporosis research (15 papers). David Doyle collaborates with scholars based in United Kingdom, United States and Ireland. David Doyle's co-authors include Tim D. Spector, Deborah Hart, D.J. Hart, Timothy D. Spector, Patricia A. Harris, Maxine Daniels, G. M. Hall, I Mootoosamy, Paul Dieppe and Tahir Masud and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Biochemical and Biophysical Research Communications.

In The Last Decade

David Doyle

90 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Doyle United Kingdom 37 3.0k 1.7k 1.4k 859 792 94 5.6k
Gabriel Herrero‐Beaumont Spain 48 4.9k 1.7× 1.7k 1.0× 985 0.7× 2.0k 2.3× 1.5k 1.9× 195 7.8k
G. Nuki United Kingdom 37 5.2k 1.8× 2.8k 1.7× 1.1k 0.7× 2.0k 2.3× 1.1k 1.3× 153 9.1k
Daniel Uebelhart Switzerland 40 2.0k 0.7× 941 0.6× 1.4k 0.9× 1.2k 1.4× 785 1.0× 110 6.0k
Jordan B. Renner United States 42 3.5k 1.2× 2.7k 1.6× 968 0.7× 1.3k 1.5× 378 0.5× 196 6.3k
N K Arden United Kingdom 13 1.9k 0.7× 1.2k 0.7× 929 0.6× 838 1.0× 394 0.5× 41 3.8k
Boulos Haraoui Canada 47 5.8k 2.0× 1.7k 1.0× 640 0.4× 1.0k 1.2× 471 0.6× 196 8.5k
Leif Dahlberg Sweden 47 4.7k 1.6× 3.9k 2.3× 1.3k 0.9× 1.2k 1.4× 886 1.1× 187 8.9k
Pierre Gillet France 38 1.7k 0.6× 1.1k 0.7× 451 0.3× 714 0.8× 740 0.9× 248 4.9k
Noriko Yoshimura Japan 51 2.4k 0.8× 3.8k 2.3× 1.4k 1.0× 1.7k 2.0× 1.3k 1.7× 202 9.1k
Roberta Ramonda Italy 43 4.2k 1.4× 1.2k 0.7× 754 0.5× 631 0.7× 797 1.0× 262 6.0k

Countries citing papers authored by David Doyle

Since Specialization
Citations

This map shows the geographic impact of David Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Doyle more than expected).

Fields of papers citing papers by David Doyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Doyle. The network helps show where David Doyle may publish in the future.

Co-authorship network of co-authors of David Doyle

This figure shows the co-authorship network connecting the top 25 collaborators of David Doyle. A scholar is included among the top collaborators of David Doyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Doyle. David Doyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janzadeh, Atousa, et al.. (2025). The role of IL-39 in autoimmune diseases: From general to immunopathogenesis. Cytokine. 192. 156969–156969.
2.
3.
Doyle, David, Bhairavi Srinageshwar, Ajit Sharma, et al.. (2025). Curcumin encapsulated in PAMAM dendrimers for the therapeutic treatment of ischemic stroke in rats. Frontiers in Cell and Developmental Biology. 12. 1467417–1467417. 3 indexed citations
4.
5.
Doyle, David, et al.. (2022). Temporal Profile of Reactive Astrocytes after Ischemic Stroke in Rats. Figshare. 3(3). 99–111. 5 indexed citations
6.
Minchinton, R. M., David Doyle, & A. H. Waters. (2008). Neutrophil surface-bound immunoglobulin-a feature of Felty's syndrome?. Clinical & Laboratory Haematology. 4(2). 131–138. 1 indexed citations
7.
8.
Martin, Finbarr C., Deborah Hart, Tim D. Spector, David Doyle, & Danielle Harari. (2005). Fear of falling limiting activity in young-old women is associated with reduced functional mobility rather than psychological factors. Age and Ageing. 34(3). 281–287. 109 indexed citations
9.
10.
Reginster, Jean‐Yves, Adam Sawicki, Jean‐Pierre Devogelaer, et al.. (2002). Strontium ranelate reduces the risk of hip fracture in women with postmenopausal osteoporosis. Open Repository and Bibliography (University of Liège). 15 indexed citations
11.
Mitchell, E., et al.. (2002). MRSA bacteraemia: North/South Study of MRSA in Ireland 1999. Journal of Hospital Infection. 52(4). 288–291. 14 indexed citations
12.
Kerr, Alison, Dawna D. Armstrong, R.J. Prescott, David Doyle, & Debra L. Kearney. (1997). Rett syndrome: analysis of deaths in the British survey.. PubMed. 6 Suppl 1. 71–4. 132 indexed citations
13.
Egger, P., Cyrus Cooper, D.J. Hart, et al.. (1995). Patterns of joint involvement in osteoarthritis of the hand: the Chingford Study.. PubMed. 22(8). 1509–13. 80 indexed citations
14.
Comer, M., D L Scott, David Doyle, E. C. Huskisson, & Ashley M. Hopkins. (1995). ARE SLOW-ACTING ANTI-RHEUMATIC DRUGS MONITORED TOO OFTEN? AN AUDIT OF CURRENT CLINICAL PRATICE. Lara D. Veeken. 34(10). 966–970. 9 indexed citations
15.
Hall, G. M., Maxine Daniels, David Doyle, & Tim D. Spector. (1994). Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis & Rheumatism. 37(10). 1499–1505. 177 indexed citations
16.
Doyle, David, et al.. (1993). THE LONG-TERM USE OF D-PENICILLAMINE FOR TREATING RHEUMATOID ARTHRITIS: IS CONTINUOUS THERAPY NECESSARY?. Lara D. Veeken. 32(7). 614–617. 22 indexed citations
17.
Masud, Tahir, et al.. (1993). Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis.. BMJ. 307(6897). 172–173. 174 indexed citations
18.
Jones, Anthony, et al.. (1991). In vivo leukocyte migration in arthritis. Arthritis & Rheumatism. 34(3). 270–275. 43 indexed citations
19.
Dieppe, P., David Doyle, & H C Burry. (1978). Renal damage during treatment with antirheumatic drugs.. BMJ. 2(6138). 664.1–664. 19 indexed citations
20.
Dieppe, Paul, David Doyle, H C Burry, & Susan Tucker. (1976). Renal disease in rheumatoid arthritis.. BMJ. 1(6010). 611–612. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriel Herrero‐Beaumont Breakdown of academic impact, for papers by G. Nuki Breakdown of academic impact, for papers by Daniel Uebelhart Breakdown of academic impact, for papers by Jordan B. Renner Breakdown of academic impact, for papers by N K Arden Breakdown of academic impact, for papers by Boulos Haraoui Breakdown of academic impact, for papers by Leif Dahlberg Breakdown of academic impact, for papers by Pierre Gillet Breakdown of academic impact, for papers by Noriko Yoshimura Breakdown of academic impact, for papers by Roberta Ramonda
Rankless by CCL
2026